ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2060

Bim Suppresses the Development of SLE By Limiting Macrophage Inflammatory Responses

FuNien Tsai1, Carla Cuda2, Harris R. Perlman3, Philip J. Homan4, Salina Dominguez2, Alexander Shaffer3, George Kenneth Haines III5 and Jack Hutcheson6, 1Medicine-Rheumatology, Northwestern University-Feinberg School of Medicine, Chicago, IL, 2Northwestern University, Chicago, IL, 3Department of Medicine, Division of Rheumatology, Northwestern University Feinberg School of Medicine, Northwestern University, Chicago, IL, 4Medicine-Rheumatology, Northwestern University, Chicago, IL, 5Mount Sinai, New York, NY, 6UT Southwestern, Dallas, TX

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Apoptosis, glomerulonephritis and toll-like receptors, Macrophage, SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Systemic Lupus Erythematosus – Animal Models

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: The Bcl-2 family guards the mitochondrial apoptotic pathway. Among numerous Bcl-2 antagonists, only the loss of Bim in mice leads to the development of SLE-like disease, suggesting Bim’s unique status that exerts dominance in several pathways that are vital for the development of SLE. However, the role that Bim plays in macrophage functions and relevance to SLE is unknown.

Methods: We generated mice lacking Bim specifically in macrophages (CreLysMBimfl/fl) and assessed mice at 8 months of age for characterization of SLE-like disease. Macrophage turnover/proliferation and activation were examined in vivo using flow cytometric analyses. To better understand the role of Bim in regulating transcriptional profile in kidney macrophages, RNA-seq analysis was performed on sorted macrophages from CreLysMBimfl/fl and Bimfl/fl mice.

Results:  CreLysMBimfl/fl mice displayed splenomegaly, lymphadenopathy, hyperglobulinemia, IC deposition in the kidney, proteinuria, GN, and early mortality as compared to Bimfl/fl and mice lacking Bim in either lymphocyte compartments. CreLysMBimfl/fl mice were lack of splenic marginal zone macrophages (MZMs) and marginal zone B cells (MZ-B cells), which is also evident in lupus patients. Bim functions in macrophages are independent of its role in apoptosis as there were no differences in the rate of EdU incorporation in macrophages from Bimfl/fl and CreLysMBimfl/fl mice. TLRs, the well-known initiators of autoimmune disease, are not required for the break in tolerance, as mice lacking MyD88 or TRIF in CreLysMBimfl/fl mice (MyD88fl/fl CreLysMBimfl/fl and TRIF -/- CreLysMBimfl/fl) developed systemic autoimmunity similar to CreLysMBimfl/fl mice. However, TRIF-/-CreLysMBimfl/fl mice did not develop end-stage GN. Consistent with these data, CreLysMBimfl/fl mice showed increased numbers of kidney macrophages, while TRIF -/- CreLysMBimfl/fl mice exhibited significantly reduced numbers as identified by multi-parameter flow cytometry. To better understand the effect of Bim deletion in kidney macrophages in vivo, we utilized RNA-seq for FACSorted kidney macrophages from young and old mice. Exploratory analysis via principal component analysis (PCA) revealed that Bim deletion affected the transcriptional profile of kidney macrophages. We were able to identify unique cellular processes up-regulated in CreLysMBimfl/fl kidney macrophages using pairwise GO processes analyses. We also identified that kidney macrophages from CreLysMBimfl/fl mice significantly up-regulate ifnar1, the receptor for IFNα and IFNβ.

Conclusion: The expression of Bim in macrophages is sufficient to inhibit SLE-like pathogenesis. Bim controls macrophage functions independent of its role in apoptosis which challenges the conventional dogma that Bim’s role in autoimmunity is to prevent the escape of autoreactive lymphocytes from apoptosis. We provide data to identify the role of kidney macrophages throughout SLE-like disease development in the context of Bim deficiency. The discovery of Bim-regulated transcriptome in kidney macrophages are crucial for translational studies leading to the development of new targets for SLE.


Disclosure: F. Tsai, None; C. Cuda, None; H. R. Perlman, None; P. J. Homan, None; S. Dominguez, None; A. Shaffer, None; G. K. Haines III, None; J. Hutcheson, None.

To cite this abstract in AMA style:

Tsai F, Cuda C, Perlman HR, Homan PJ, Dominguez S, Shaffer A, Haines GK III, Hutcheson J. Bim Suppresses the Development of SLE By Limiting Macrophage Inflammatory Responses [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/bim-suppresses-the-development-of-sle-by-limiting-macrophage-inflammatory-responses-2/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/bim-suppresses-the-development-of-sle-by-limiting-macrophage-inflammatory-responses-2/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology